- Home
- BNR vs LEGT Comparison
BNR vs LEGT Comparison
Compare BNR & LEGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BNR | LEGT |
|---|---|---|
| Founded | 2014 | 2023 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.7M | 282.2M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BNR | LEGT |
|---|---|---|
| Price | $16.20 | $11.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 31.2K | ★ 114.8K |
| Earning Date | 03-12-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $111.65 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $35.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.18 | $10.44 |
| 52 Week High | $41.72 | $11.50 |
Technical Indicators
Market Signals| Indicator | BNR | LEGT |
|---|---|---|
| Relative Strength Index (RSI) | 35.63 | 55.70 |
| Support Level | $15.52 | $10.84 |
| Resistance Level | $23.42 | $11.10 |
| Average True Range (ATR) | 1.39 | 0.03 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 11.27 | 37.50 |
Price Performance
Historical ComparisonAbout BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.